All In MedTech

FDA Clearance Tracker · P010059-S004

EYEJET INJECTOR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 23, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 23, 2013

Approved

Time to decision

562 days

Received Nov 8, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010059-S004
Device name
EYEJET INJECTOR
Applicant
Morcher GmbH
Applicant location
Stuttgart
Received
Nov 8, 2011
Decided
May 23, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010059

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MRJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE EXPANSION OF YOUR FAMILY OF CAPSULAR TENSION RINGS (CTRS) AVAILABLE PRE-LOADED ON THE EYEJET INJECTOR TO INCLUDE NEW CTR MODELS TYPE 10G, 10L, 15, 15A, AND 15B. IN ADDITION, YOU REQUESTED APPROVAL TO SUPPLY CURRENTLY APPROVED CTR TYPE 10C AS PRE-LOADED ON THE EYEJET INJECTOR.

Source documents

Other decisions for Morcher GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.